华为WATCH D2新增定时血压提醒功能，以用户需求为核心的体验升级

Core Viewpoint - The article highlights the advancement of Huawei's WATCH D2 in the health management sector, particularly focusing on hypertension monitoring, addressing a significant public health issue in China with 245 million patients affected by high blood pressure [3][12]. Group 1: Product Features and Innovations - Huawei WATCH D2 features a new design with a "strap airbag integration + quick-release system," allowing for precise and comfortable blood pressure measurements [5][7]. - The device offers 24-hour dynamic blood pressure monitoring and new timed measurement options, catering to various user needs, including those with morning and nighttime hypertension [5][12]. - It is the first smartwatch to receive medical certification for dynamic blood pressure monitoring, utilizing the "oscillometric method + cuff" technology, recognized as essential for accurate measurement [7][12]. Group 2: Market Context and Health Impact - High blood pressure is a major health concern in China, with a patient awareness rate of only 51.6%, leading to ineffective disease management [3][12]. - The WATCH D2 aims to fill the gap in portable monitoring devices, providing a reliable tool for daily blood pressure management for the large hypertensive population [13]. - The product extends health management capabilities beyond blood pressure monitoring, offering features like heart rate and sleep monitoring, and enabling family health management through the Huawei Health app [12][13]. Group 3: Industry Position and Future Outlook - Huawei's decade-long investment in health technology positions it as a leader in the wearable medical device market, setting industry standards and promoting proactive health management [13]. - The WATCH D2 represents a shift from passive treatment to active prevention in health management, potentially transforming how individuals and families monitor and manage health [13].